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Background: Up to 25% of stroke patients wake up with a neurological deficit, so called wake-up stroke (WUS).
Different imaging approaches that may aid in the selection of patients likely to benefit from reperfusion therapy
are currently under investigation. The magnetic resonance imaging (MRI) diffusion weighted imaging – fluid
attenuated inversion recovery (DWI-FLAIR) mismatch concept is one proposed method for identifying patients
presenting within 4.5 hours of the ischemic event.
Purpose: To report our experience with the DWI-FLAIR mismatch concept for selection of wake-up stroke patients to
be thrombolysed at our centre.
Material and methods: Patients treated with off label intravenous thrombolysis (IVT) for WUS at our centre during a
6.5-month period were included. We performed MRI including DWI and FLAIR in all patients at admission. Each MRI
examination was rated as either DWI-FLAIR mismatch or match. National Institutes of Health Stroke Scale (NIHSS) and
modified Rankin Scale were used to measure clinical outcome. Cerebral computed tomography (CT) or MRI was
performed within 24 hours after thrombolysis to determine the presence of any intracranial haemorrhage (ICH).
Results: Ten patients treated with IVT for WUS were included. Four patients had a DWI-FLAIR mismatch and after
IVT treatment the mean reduction in NIHSS in the DWI-FLAIR mismatch group was 4.0. In the DWI-FLAIR match
group the mean reduction in NIHSS after IVT therapy was 4.8. None of the ten patients had any signs of ICH on
follow-up imaging.
Conclusions: In this small series DWI-FLAIR mismatch was not associated with worse outcome or ICH. This suggests
that selecting WUS patients using DWI-FLAIR mismatch in clinical trials may exclude a large group of patients who
might benefit.
Keywords: Brain, Diagnosis, Magnetic resonance imaging (MRI), Acute ischemic stroke, Fluid attenuated inversion
recovery (FLAIR), Diffusion weighted imaging (DWI), MismatchBackground
Results from large randomized controlled trials have
shown a clear benefit for intravenous thrombolysis (IVT)
when patients with ischemic stroke are treated within 4.5
hours (hrs) of symptom onset [1,2]. If IVT is administered
later than 4.5 hrs after symptom onset, the risk of harm* Correspondence: kathinka.dehli.kurz@sus.no
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unless otherwise stated.exceeds potential benefit [3]. In a large subgroup of pa-
tients with ischemic stroke the exact time of symptom
onset is unknown. Up to 25% of patients wake from
sleep with a neurological deficit; a so called wake-up
stroke (WUS) [4,5]. It is still unclear if these patients
benefit from thrombolytic therapy [6]. Several studies
suggest that the majority of these strokes occur close to
the time of awakening [7-9]. According to current
guidelines, symptom onset is defined as the last docu-
mented time the patient was known to be asymptomatic. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ing IVT treatment.
Different imaging modalities that may aid in patient
selection for reperfusion therapy are currently under inves-
tigation. Besides the traditional non-enhanced computed
tomography (CT) and perfusion-CT, two different mag-
netic resonance imaging (MRI) techniques are discussed
[11]. The diffusion weighted imaging-fluid attenuated
inversion recovery (DWI-FLAIR) mismatch concept in-
directly estimates time of the ischemic event [12]. Pen-
umbral imaging estimates the volume of hypoperfused
tissue which is not irreversibly damaged, using DWI
and perfusion imaging [13]. At our centre (Stavanger
University Hospital), the MRI protocol for WUS patients
includes both DWI and FLAIR series. However, the DWI-
FLAIR mismatch concept is not rigorously used to exclude
patients from IVT. The DWI-FLAIR mismatch concept
has been shown to identify patients presenting within 4.5
hrs of symptom onset with a high positive predictive value
(83–87%) [12,14]. Nonetheless, we believe that too many
WUS patients are excluded from the benefits of IVT when
strictly adhering to the mismatch concept. Subsequently,
we present here our experience with the DWI-FLAIR mis-
match concept in these patients.
Material and methods
Patient selection
We retrospectively identified WUS patients treated with
off label IVT at Stavanger University Hospital between
06.11.2013 and 22.05.2014. All consecutive wake up pa-
tients who were eligible for intravenous thrombolysis were
included. The WUS patients met the following criteria: (a)
asymptomatic <12 but >4.5 hrs from onset; (b) patients
could report that they woke with stroke symptoms or were
seen to have deficits on awakening; (c) diffusion restriction
in less than 1/3 of the middle cerebral artery territory on
DWI; (d) fulfilling all other IVT treatment criteria. There
were no patients eligible for thrombolysis and considered
to have WUS who did not get treatment, neither because
of contraindications for MRI nor contraindications for
thrombolysis found on MR or CT images; such as hae-
morrhages, restricted diffusion in more than 1/3 of the
middle cerebral artery territory on DWI or intracranial
tumours found.
Radiological imaging
All patients underwent an initial cerebral MRI. The MRI
protocol comprised transversal DWI (b-factor 0 and 1000),
transversal T2-weighted imaging, transversal FLAIR im-
aging, transversal T2* weighted imaging and transversal
time of flight arterial MR angiography; representing a total
scan time of 15 minutes. To save time, MR angiography
was not performed in one patient (patient 5) who had
undergone a CT examination with CT perfusion and CTangiography of precerebral and intracranial arteries prior
to the MRI. All MR scans were performed on 1.5 Tesla
MRI machines (GE Discovery 450, Philips Intera, Philips
Ingenia). Follow up imaging with unenhanced CT or MRI
was performed within 24 hours after IVT treatment to
verify infarction, any eventual haemorrhagic complications
and evaluate prognosis.
Imaging interpretation and the DWI-FLAIR mismatch
concept
Diffusion restriction (positive DWI) was defined as in-
creased signal on DWI b 1000, and corresponding reduced
apparent diffusion coefficient (ADC) values. Increased
signal on FLAIR images in the same area as the restricted
diffusion was defined as positive FLAIR, whilst a nor-
mal signal on the FLAIR images was defined as negative
FLAIR. DWI-FLAIR mismatch (Figure 1B) required positive
DWI and negative FLAIR, as defined in previous studies
[12,14-16]. DWI-FLAIR match was consequently defined as
a positive DWI and a positive FLAIR (Figure 1A). In con-
cordance with the study of Thomalla and coauthors, FLAIR
was scored as positive even if only small areas of high signal
on FLAIR images were identified within larger areas of re-
stricted diffusion [12]. We did not use DWI-FLAIR match
as strict exclusion criteria for IVT treatment. For study pur-
poses 3 radiologists re-evaluated the initial MRI examina-
tions performed on admission and reached a consensus on
the DWI-FLAIR evaluation. The size of the largest positive
DWI lesion in each patient was defined as the largest trans-
versal diameter.
Safety evaluation
The presence of intracranial haemorrhage (ICH) on post
treatment CT or MRI was recorded. ICH was classified
as in the European Cooperative Acute Stroke Study II
(ECASS II) [17].
Clinical evaluation
Neurologic deficit was graded on admission and at dis-
charge using the National Institutes of Health Stroke Scale
(NIHSS) [18-20]. The modified Rankin Scale (mRS) was
used to assess the degree of disability or dependence in
the daily activities [21]. The patients were retrospectively
assessed for their mRS prior to the ischemic stroke and
then assessed three months after.
Ethics
Patients were prospectively collected and only included
in this study after informed written consent was given.
After retrospective analysis of the results, we now include
our WUS patients in a nationwide, prospective study
(NOR-TEST) to enhance the number of WUS available
for analysis. The study was approved by the Regional
Ethics Committee.
Figure 1 Summary of data from the ten included patients. Example of diffusion weighted imaging – fluid attenuated inversion recovery
(DWI-FLAIR) match (A) and mismatch (B). The DWI images are with b-value 1000. The apparent diffusion coefficient (ADC) maps are also displayed. The
FLAIR image in B also illustrates the common problem with motion artifacts in these patients. The images in A are from patient 5 and the images in B
from patient 6.
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A total of ten patients presenting with WUS were treated
with off-label IVT during the study period (Table 1). The
mean age of the patients was 66 years (range 33 – 90
years). Most ischemic lesions were small, five patients pre-
senting with DWI lesions < 15 mm. One patient had an
infratentorial lesion (patient 7) and one patient (patient 8)
had ischemic lesions in the posterior cerebral artery terri-
tory. Despite the ischemic lesions on DWI being small,
several patients had significant neurologic deficits; e.g.
patient 2, with multiple small DWI lesions in the water-
shed area following the occlusion of one branch of the
M1 segment of the right middle cerebral artery (MCA).
No patients suffered from intracranial haemorrhage after
reperfusion therapy (ECASS II grade 0).
Follow up imaging with CT or MRI was performed 24
hrs after IVT treatment in nine patients. In one patient
(patient 10) the follow up imaging was performed 10 hrs
after IVT treatment.
Four patients had a clear DWI-FLAIR mismatch (patient
6, 7, 9 and 10). They received IVT treatment and had a re-
duction in NIHSS of 4.0 on average (range 8 – 2). None ofthese patients had signs of ICH on follow up imaging with
CT or MRI.
Four patients had a clear DWI-FLAIR match (patient
3, 4, 5 and 8). In two patients, classification into DWI-
FLAIR mismatch or match group was challenging. The
first patient (patient 1) with extensive confluating hyper-
intense white matter lesions on FLAIR images presented
with an area of positive DWI in the same area. There
was a definite DWI-FLAIR match, but it is possible that
the increased signal on the FLAIR images was a result of
chronic and not acute ischemia in that area. This case
was classified as DWI-FLAIR match. Another patient
(patient 2) presenting with multiple transitory ischemic
attacks (TIAs) within the preceding 24 hrs had multiple
small (3–10 mm) lesions with positive DWI. Some of
these, mainly the largest, also had a hyperintense signal
on the FLAIR images in the corresponding area. However,
it was not possible to decide which lesion was responsible
for the acute clinical symptoms. This patient was also
classified as DWI-FLAIR match. The patients with a
DWI-FLAIR match received IVT treatment and had a
mean reduction in NIHSS of 4.8 (range 9 – 0) (Table 1).
Table 1 Summary of results from the ten included patients




DWI-FLAIR Therapy NIHSS at
discharge
mRS before stroke
and at 3 months
MRA/CTA
1 86 5 16 mm Match IVT 5 3 - 4 M1 stenosis
2 68 8 10 mm Match IVT 2 0 - 1 M1 branch occlusion Improved FU
3 53 5 12 mm Match IVT 0 0 - 0 Normal
4 33 9 58 mm Match IVT and EVT 0 0 - 1 M1 occlusion Normal FU
5 64 8 22 mm Match IVT 1 0 - 0 CTA normal
6 51 19 26 mm Mismatch IVT and EVT 11 0 - 2 ICA MCA occlusion Normal FU
7 79 3 13 mm Mismatch IVT 1 2 - 2 Normal
8 90 3 7 mm Match IVT 1 3 - 3 P1 occlusion no FU
9 70 3 8 mm Mismatch IVT 0 0 - 2 Normal
10 65 4 16 mm Mismatch IVT 1 4 - 4 Stenosis M1, no FU
NIHSS: National Institutes of Health Stroke Scale. DWI: Diffusion Weighted Imaging. FLAIR: Fluid Attenuated Inversion Recovery. IVT: Intravenous thrombolysis.
EVT: Endovascular thrombectomy. mRS: Modified Rank scale. MRA: MR angiography of the intracranial arteries in time of flight (TOF) technique. CTA: Computed
tomography angiography of the precerebral and intracranial arteries. M1: M1 segment of the middle cerebral artery. P1: P1 segment of the posterior cerebral artery.
ICA: Internal carotid artery. FU: Follow up CT or MR examination.
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endovascular treatment. None of the patients with a
DWI-FLAIR match showed ICH on follow up imaging
with CT (patient 1, 3, 5 and 8) and MRI (patient 2 and 4).
On time of flight intracranial MR angiography (MRA)
three patients had normal findings, one patient had a
M1 occlusion, one patient an occluded branch of the
MCA, two patients showed stenoses in the M1 segment
with reduced flow signal distal to the stenosis, one patient
showed a P1 occlusion and one patient had a tandem
occlusion in the internal carotid artery (ICA) and MCA.
Follow up MR examination was not performed in all
patients, however, one of the M1 occlusions (patient 4),
the MCA branch occlusion (patient 2) and the tandem
occlusion (patient 6) all showed restored flow signal on
the MRA classified as TICI 3.
Three patients (3/6 = 50%) in the DWI-FLAIR match
group showed a drop in mRS of one point each at three
months compared to their mRS before the stroke. In the
mismatch group two patients (2/4 = 50%) showed a drop
in mRS of two points each. One patient (patient 10) was
severely disabled (mRS 4) before the stroke event. This
was a 65 years old male with bilateral blindness and mild
cognitive impairment.
Discussion
Although the presented cohort of ten patients is too
small to draw general conclusions, we can show that six
of the ten patients (60%) would have been excluded from
IVT treatment if strict DWI-FLAIR mismatch criteria
would have been adhered to [12]. All patients in this
study received IVT treatment, yet only four patients had
an indisputable DWI-FLAIR mismatch. No ICH was
seen in either of the patient groups on follow up im-
aging; DWI-FLAIR mismatch versus DWI-FLAIR match.Both patient groups had similar improvements in NIHSS:
4 versus 4.8 respectively. The safety of IVT treatment in
WUS patients without absolute contraindications on
initial imaging was also confirmed in a recent study by
Manawadu and colleagues [22]. Their study compared
68 WUS patients treated with IVT without any or only
early ischemic changes on initial CT-imaging alongside
326 patients treated with IVT within 4.5 hrs. Their re-
sults, in congruence with ours, show that both groups
profited equally (4 point improvement in NIHSS) with
the same incidence of ICH (22% versus 20%, respectively)
and symptomatic ICH (sICH) (2.9% versus 3.4%, respect-
ively) on follow up imaging. These results highlight that
IVT treatment is a beneficial therapeutic modality in acute
stroke patients treated within 4.5 hrs [10]. Additionally,
the authors conclude that IVT treatment seems to be a
safe and feasible option in WUS patients without radio-
logical contraindications [22,23].
The introduction of the DWI-FLAIR mismatch concept
for identification of WUS patients within 4,5 hrs of symp-
tom onset is clearly advantageous [12,14]. In the study by
Thomalla et al. DWI-FLAIR mismatch identified patients
within 4.5 hrs of symptom onset with a positive predictive
value (PPV) of 0.83, a negative predictive value (NPV) of
0.54, sensitivity of 0.62 and specificity of 0.78 [12]. Lesion
size was identified as a confounding factor due to the fact
that this method is less suitable for smaller lesions; also
verified by another study [16]. A similar study by Aoki
et al. identified DWI-FLAIR mismatch patients within 4.5
hrs of symptom onset with a PPV of 0.87, NPV of 0.70,
sensitivity of 0.74 and specificity of 0.85; this study
excluded patients with lacunar infarctions (<15 mm),
infratentorial infarctions or severe leukaraiosis [14].
Both the afore mentioned studies have a high PPV, sug-
gesting that WUS patients with a larger ischemic lesion
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be within 4.5 hours of symptom onset. However, the
study by Thomalla et al. has a relatively low NPV (0.54)
highlighting that many patients presenting within 4.5
hrs already have a DWI-FLAIR match [12]. Rigorous use
of the DWI-FLAIR mismatch concept would exclude
these patients from IVT treatment.
Ongoing trials selecting patients either with WUS
(WAKE-UP trial) or beyond the 4.5 time window (EXTEND
trial) based on identification of significant salvageable brain
tissue may further contribute to better select patients
profiting from IVT [24,25].
Our study has its limitations: The sample size is too
low to draw any firm conclusions and the retrospective
nature of the study is a clear disadvantage. We see that
the infarct size in our study is on average small. Despite
the DWI lesions being small, several patients showed large
vessel occlusions on MRA, and one would therefore ex-
pect that some of the ischemic lesions seen on DWI would
progress if not thrombolysed. We can add to the body of
evidence that the DWI-FLAIR mismatch concept is just a
stepping stone to other, more reliable imaging techniques.
Techniques such as multiparametric CT and MRI may
have the advantage of estimating penumbra more precisely
and giving us a more reliable indication of salvageable
brain tissue [26]. However, optimal methods for evaluating
penumbra are still under investigation [11].
In this small series DWI-FLAIR mismatch was not as-
sociated with worse outcome or ICH. This suggests that
selecting WUS patients using DWI-FLAIR mismatch in
clinical trials may exclude a large group of patients who
might benefit. Clearly more research is warranted to lead
to advances in this field.
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